amd chips news - Search News

AMD, Ryzen AI

Apple Silicon's success helped AMD make Ryzen AI Max chips

AMD's latest Ryzen AI Max chips probably wouldn't have existed without Apple, an AMD executive has admitted, thanks to the popularity of Apple Silicon.

PC World on MSN · 3d

AMD builds out its foundation with Ryzen AI 300, Ryzen 200 chips

AMD is pushing into more mainstream computing with the launch of new Ryzen AI 300 chips and a new Ryzen 200 CPU family.

Engadget on MSN · 23h

AMD VP explains why the Ryzen AI Max likely wouldn't exist without Apple

AMD's Ryzen AI Max chips came as a huge surprise at CES 2025. They're basically super-powered versions of the company's Ryzen AI hardware with up to 16 CPU cores and 50 RDNA 3.5 graphics cores, alongside a pool of as much as 128GB integrated RAM.

9to5Mac · 9h

AMD does and doesn’t credit Apple for its powerful new Ryzan AI Max chips

Not only has Apple left its CPUs in the dust, but AMD’s new Ryzan AI Max chips claim to do the same to Intel’s flagship Core Ultra 9 288V. The new chips take the same approach as Apple Silicon in combining CPU,

DMR News (English) on MSN · 1d

AMD Pushes AI PCs Further with Ryzen AI Max Chips

AMD has unveiled its ambitious plan to cater to a wide range of AI-powered PCs at CES 2025, introducing the new Ryzen AI Max chips for high-end “halo” Copilot+ AI PCs. Positioned above the existing Ryzen AI 9 systems,

AMD invests $20 million in AI drug research

Hosted on MSN · 1d

AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Business Insider · 1d

AMD partnering with drug-discovery company Absci

AMd (AMD) said via X that it is partnering with drug-discovery company Absci (ABSI). “AMD is proud to announce we are partnering with @abscibio

Oregonian · 1d

AMD invests $20 million in AI drug research at Vancouver-based Absci

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies. Absci hopes artificial intelligence will enable it to move faster to develop protein-based medicines called biologics,

2don MSN

AMD unveils new chips for laptops, desktops, and gaming handhelds at CES 2025

At CES 2025 in Las Vegas, AMD unveiled a slew of new chips destined for devices ranging from desktops to gaming handhelds.

1don MSN

AMD Stock Slumps After Downgrade. Why It’s Trailing in the AI Chips Race.

Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...

9hon MSN

Qualcomm's Budget PC Chips Don't Solve Its Biggest Problem

This emulation works well most of the time, but not all the time. This is the biggest problem with Qualcomm's PC chips, and ...

Interesting Engineering on MSN2d

AMD’s new AI PC chips deliver unmatched gaming and content creation power

AMD claims the Ryzen 9000 CPUs are up to 8% faster than the previous Ryzen 9 7950X3D, with improvements in games like Black ...

2don MSN

AMD brings back 3D V-Cache chips for gaming laptops

As part of its high-end gaming laptop chip lineup, AMD has announced the Ryzen 9 9955HX3D, bringing 3D V-Cache to mobile for ...

12h

Unpacking Q3 Earnings: AMD (NASDAQ:AMD) In The Context Of Other Processors and Graphics Chips Stocks

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

AMD’s Ryzen 9 9950X3D — best processor for gamers and creators — is among many new chips coming

Lisa Su, CEO of AMD, said at CES 2025 that the AMD Ryzen 9 9950X3D is the best processor for gamers and creators.

6hon MSN

AMD on HX3D chip shortages: ‘Competitor had built such a horrible [part]’

AMD explains why stockpiles of its Ryzen 9000HX3D chip disappeared almost overnight in an interview from CES 2025.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

AMD, Ryzen AI

AMD invests $20 million in AI drug research

Related topics